About this Journal Submit a Manuscript Table of Contents
Arthritis
Volume 2012 (2012), Article ID 560634, 28 pages
http://dx.doi.org/10.1155/2012/560634
Review Article

Prescribing Optimal Nutrition and Physical Activity as “First-Line” Interventions for Best Practice Management of Chronic Low-Grade Inflammation Associated with Osteoarthritis: Evidence Synthesis

1Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada V6T 1Z3
2Department of Physical Therapy, Ringsted and Slagelse Hospitals, Region Zealand, Denmark

Received 7 August 2012; Revised 23 November 2012; Accepted 24 November 2012

Academic Editor: Pierre Youinou

Copyright © 2012 Elizabeth Dean and Rasmus Gormsen Hansen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Brosseau, G. A. Wells, P. Tugwell et al., “Ottawapanel evidence-based clinical practice guidelines for the management of osteoarthritis in adults who are obese or overweight,” Physical Therapy, vol. 91, no. 6, pp. 843–860, 2011. View at Publisher · View at Google Scholar
  2. M. C. Hochberg, R. D. Altman, K. T. April et al., “American College of Rheumatology 2012. Recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee,” Arthritis Care Research, vol. 64, pp. 465–474, 2012.
  3. N. E. Lane and J. M. Thompson, “Management of osteoarthritis in the primary-care setting: an evidence- based approach to treatment,” American Journal of Medicine A, vol. 103, no. 6, pp. 25S–30S, 1997. View at Scopus
  4. Osteoarthritis, “National clinical guideline for care and management in adults,” The National Collaborative Centre for Chronic Conditions. Royal College of Physicians of London, http://bookshop.rcplondon.ac.uk/contents/pub242-66a1af7e-27ae-4121-bd84-6b503c80a64e.pdf, 2008.
  5. W. Zhang, G. Nuki, R. W. Moskowitz et al., “OARSI recommendations for the management of hip and knee osteoarthritis. Part III: changes in evidence following systematic cumulative update of research published through January 2009,” Osteoarthritis and Cartilage, vol. 18, no. 4, pp. 476–499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Barr and P. G. Conaghan, “Osteoarthritis: a holistic approach,” Clinical Medicine, vol. 12, no. 2, pp. 153–155, 2012.
  7. N. Hairon, “New guidance on osteoarthritis focuses on patient education,” Nursing times, vol. 104, no. 10, pp. 21–22, 2008. View at Scopus
  8. R. I. Issa and T. M. Griffin, “Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation,” Pathobiology of Aging and Age Related Diseases, vol. 2012, Article ID 17470, 2 pages, 2012. View at Publisher · View at Google Scholar
  9. D. L. Cecil, K. Johnson, J. Rediske, M. Lotz, A. M. Schmidt, and R. Terkeltaub, “Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products,” Journal of Immunology, vol. 175, no. 12, pp. 8296–8302, 2005. View at Scopus
  10. J. Rojas-Rodríguez, L. E. Escobar-Linares, M. Garcia-Carrasco, R. O. Escárcega, S. Fuentes-Alexandro, and A. Zamora-Ustaran, “The relationship between the metabolic syndrome and energy-utilization deficit in the pathogenesis of obesity-induced osteoarthritis,” Medical Hypotheses, vol. 69, no. 4, pp. 860–868, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Schlesinger and R. G. Thiele, “The pathogenesis of bone erosions in gouty arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 11, pp. 1907–1912, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. D. Smith, S. Triantafillou, A. Parker, P. P. Youssef, and M. Coleman, “Synovial membrane inflammation and cytokine production in patients with early osteoarthritis,” Journal of Rheumatology, vol. 24, no. 2, pp. 365–371, 1997. View at Scopus
  13. E. Dean, S. Al-Obaidi, A. D. de Andrade et al., “The first physical therapy summit on global health: implications and recommendations for the 21st century,” Physiotherapy Theory and Practice, vol. 27, no. 8, pp. 531–547, 2011.
  14. World Health Organization, Chronic Diseases, http://www.who.int/topics/chronic_diseases/en/, 2005.
  15. P. Carrera-Bastos, M. Fontes-Villalba, J. H. O. Keefe, S. Lindeberg, and L. Cordain, “The western diet and lifestyle and diseases of civilization,” Research Reports in Clinical Cardiology, vol. 2, pp. 15–35, 2012.
  16. B. Caballero, “Obesity as a consequence of undernutrition,” Journal of Pediatrics, vol. 149, no. 3, pp. S97–S99, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Engström, M. Gerhardsson de Verdier, J. Rollof, P. M. Nilsson, and L. S. Lohmander, “C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study,” Osteoarthritis and Cartilage, vol. 17, no. 2, pp. 168–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Landaeta-Díaz, J. M. Fernández, M. Da Silva-Grigoletto et al., “Mediterranean diet, moderate-to-high intensity training and health-related quality of life in adults with metabolic syndrome,” European Journal of Preventive Cardiology. In press. View at Publisher · View at Google Scholar
  19. T. C. Campbell, “A study on diet, nutrition and disease in the People's Republic of China. Part I,” Boletin de la Asociacion Medica de Puerto Rico, vol. 82, no. 3, pp. 132–134, 1990. View at Scopus
  20. T. C. Campbell and C. Junshi, “Diet and chronic degenerative diseases: perspectives from China,” American Journal of Clinical Nutrition, vol. 59, supplement 1, pp. 1153S–1153S, 1994. View at Scopus
  21. T. C. Campbell and T. M. Campbell, The China Study, Benbella Books, Dallas, Tex, USA, 2006.
  22. T. C. Campbell, B. Parpia, and J. Chen, “Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China Study,” American Journal of Cardiology B, vol. 82, no. 10, pp. 18T–21T, 1998. View at Scopus
  23. S. Gregersen, D. Samocha-Bonet, L. K. Heilbronn, and L. V. Campbell, “Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans,” Journal of Nutrition and Metabolism, vol. 2012, Article ID 238056, 8 pages, 2012. View at Publisher · View at Google Scholar
  24. B. J. Nicklas, W. Ambrosius, S. P. Messier et al., “Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial,” American Journal of Clinical Nutrition, vol. 79, no. 4, pp. 544–551, 2004. View at Scopus
  25. M. A. Allison, N. E. Jensky, S. J. Marshall, A. G. Bertoni, and M. Cushman, “Sedentary behavior and adiposity-associated inflammation: the multi-ethnic study of atherosclerosis,” American Journal of Preventive Medicine, vol. 42, no. 1, pp. 8–13, 2012. View at Publisher · View at Google Scholar
  26. M. Gleeson, N. C. Bishop, D. J. Stensel, M. R. Lindley, S. S. Mastana, and M. A. Nimmo, “The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease,” Nature Reviews Immunology, vol. 11, no. 9, pp. 607–615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. A. M. W. Petersen and B. K. Pedersen, “The anti-inflammatory effect of exercise,” Journal of Applied Physiology, vol. 98, no. 4, pp. 1154–1162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. Exercise helps ease arthritis pain and stiffness, http://www.mayoclinic.com/health/arthritis/AR00009, 2012.
  29. N. P. Walsh, M. Gleeson, R. J. Shephard et al., “Position statement. Part one: immune function and exercise,” Exercise Immunology Review, vol. 17, pp. 6–63, 2011. View at Scopus
  30. M. Gurevich, P. M. Kohn, and C. Davis, “Exercise-induced analgesia and the role of reactivity in pain sensitivity,” Journal of Sports Sciences, vol. 12, no. 6, pp. 549–559, 1994. View at Scopus
  31. R. B. Singh, G. Dubnov, M. A. Niaz et al., “Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial,” The Lancet, vol. 360, no. 9344, pp. 1455–1461, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Lee, V. Taneja, and R. Vassallo, “Cigarette smoking and inflammation cellular and molecular mechanisms,” Journal of Dental Research, vol. 91, no. 2, pp. 142–149, 2012. View at Publisher · View at Google Scholar
  33. R. B. Gonçalves, R. D. Coletta, K. G. Silvério et al., “Impact of smoking on inflammation: overview of molecular mechanisms,” Inflammation Research, vol. 60, no. 5, pp. 409–424, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Bakhru and T. P. Erlinger, “Smoking cessation and cardiovascular disease risk factors: results from the third national health and nutrition examination survey,” PLoS Medicine, vol. 2, no. 6, pp. 0528–0536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Baka, E. Buzás, and G. Nagy, “Rheumatoid arthritis and smoking: putting the pieces together,” Arthritis Research & Therapy, vol. 11, no. 4, p. 238, 2009. View at Scopus
  36. S. Amin, J. Niu, A. Guermazi et al., “Cigarette smoking and the risk for cartilage loss and knee pain in men with knee osteoarthritis,” Annals of the Rheumatic Diseases, vol. 66, no. 1, pp. 18–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. P. H. Black, “Stress and the inflammatory response: a review of neurogenic inflammation,” Brain, Behavior, and Immunity, vol. 16, no. 6, pp. 622–653, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. P. H. Black, “The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X,” Brain, Behavior, and Immunity, vol. 17, no. 5, pp. 350–364, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Cohen, D. Janicki-Deverts, W. J. Doyle et al., “Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk,” Proceedings of the National Academy of Science, vol. 109, no. 16, pp. 5995–5999, 2012. View at Publisher · View at Google Scholar
  40. M. Maes, “Psychological stress and the inflammatory response system,” Clinical Science, vol. 101, no. 2, pp. 193–194, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Pedersen, “Lack of sleep, stress leads to inflammation in older adults,” Psychology Central, http://psychcentral.com/news/2012/03/02/lack-of-sleep-stress-leads-to-inflammation-in-older-adults/35490.html, 2012.
  42. B. Giunta, F. Fernandez, W. V. Nikolic et al., “Inflammaging as a prodrome to Alzheimer's disease,” Journal of Neuroinflammation, vol. 5, p. 51, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Veerhuis, “Histological and direct evidence for the role of complement in the neuroinflammation of AD,” Current Alzheimer Research, vol. 8, no. 1, pp. 34–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Candore, C. Caruso, E. Jirillo, T. Magrone, and S. Vasto, “Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement,” Current Pharmaceutical Design, vol. 16, no. 6, pp. 584–596, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. K. T. Chou, C. C. Huang, Y. M. Chen et al., “Asthma and risk of erectile dysfunction-A nationwide population-based study,” Journal of Sexual Medicine, vol. 8, no. 6, pp. 1754–1760, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Dixon, “The treatment of asthma in obesity,” Expert Reviews in Respiratory Medicine, vol. 6, no. 3, pp. 331–340, 2012. View at Publisher · View at Google Scholar
  47. C. T. Juel, Z. Ali, L. Nilas, and C. S. Ulrik, “Asthma and obesity: does weight loss improve asthma control? A systematic review,” Journal of Asthma and Allergy, vol. 5, pp. 21–26, 2012.
  48. H. F. Gu, C. K. Tang, and Y. Z. Yang, “Psychological stress, immune response, and atherosclerosis,” Atherosclerosis, vol. 223, no. 1, pp. 69–77, 2012. View at Publisher · View at Google Scholar
  49. E. J. Kucharz, “Chronic inflammation-enhanced atherosclerosis: can we consider it as a new clinical syndrome?” Medical Hypotheses, vol. 78, no. 3, pp. 396–397, 2012. View at Publisher · View at Google Scholar
  50. X. T. Lu, Y. F. Liu, L. Zhang et al., “Unpredictable chronic mild stress promotes atherosclerosis in high cholesterol-fed rabbits,” Psychosomatic Medicine, vol. 74, no. 6, pp. 604–611, 2012. View at Publisher · View at Google Scholar
  51. E. Ortega, R. Gilabert, I. Nuñez et al., “White blood cell count is associated with carotid and femoral atherosclerosis,” Atherosclerosis, vol. 221, no. 1, pp. 275–281, 2012. View at Publisher · View at Google Scholar
  52. A. Pinto, D. Di Raimondo, A. Tuttolomondo, C. Buttà, G. Milio, and G. Licata, “Effects of physical exercise on inflammatory markers of atherosclerosis,” Current Pharmaceutical Design, vol. 18, no. 28, pp. 4326–4349, 2012. View at Publisher · View at Google Scholar
  53. P. Correa and M. B. Piazuelo, “The gastric precancerous cascade,” Journal of Digestive Diseases, vol. 13, no. 1, pp. 2–9, 2012. View at Publisher · View at Google Scholar
  54. S. Peters, N. Grunwald, P. Rümmele et al., “Chronic psychosocial stress increases the risk for inflammation-related colon carcinogenesis in male mice,” Stress, vol. 15, no. 4, pp. 403–415, 2012. View at Publisher · View at Google Scholar
  55. L. A. Cox Jr, “Dose-response thresholds for progressive diseases,” Dose Response, vol. 10, no. 2, pp. 233–250, 2012. View at Publisher · View at Google Scholar
  56. A. Lindberg, L. G. Larsson, E. Rönmark, and B. Lundbäck, “Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function,” Chronic Obstructive Pulmonary Disease, vol. 8, no. 6, pp. 421–428, 2011. View at Publisher · View at Google Scholar
  57. N. H. T. ten Hacken, “Physical inactivity and obesity: relation to asthma and chronic obstructive pulmonary disease?” Proceedings of the American Thoracic Society, vol. 6, no. 8, pp. 663–667, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. E. F. M. Wouters, N. L. Reynaert, M. A. Dentener, and J. H. J. Vernooy, “Systemic and local inflammation in asthma and chronic obstructive pulmonary disease is there a connection?” Proceedings of the American Thoracic Society, vol. 6, no. 8, pp. 638–647, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. C. M. Chang, C. J. Hsieh, J. C. Huang, and I. C. Huang, “Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus,” Acta Diabetologica, vol. 49, no. 1 Supplement, pp. 171–177, 2012.
  60. B. C. van Bussel, S. S. Soedamah-Muthu, R. M. Henry et al., “EURODIAB Prospective Complications Study Group, Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: The EURODIAB study,” Nutrition and Metabolism in Cardiovascular Disease. In press.
  61. D. Kadetoff, J. Lampa, M. Westman, M. Andersson, and E. Kosek, “Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels,” Journal of Neuroimmunology, vol. 242, no. 1-2, pp. 33–38, 2012.
  62. E. Ortega, M. E. Bote, E. Giraldo, and J. J. García, “Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients,” Scandinavian Journal of Medical Science and Sports, vol. 22, no. 1, pp. 104–112, 2012. View at Publisher · View at Google Scholar
  63. A. Berni, E. Ciani, M. Bernetti et al., “Renal resistive index and low-grade inflammation in patients with essential hypertension,” Journal of Human Hypertension, vol. 26, no. 12, pp. 723–730, 2012. View at Publisher · View at Google Scholar
  64. H. He, Z. Zhao, J. Chen et al., “Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial,” Journal of Hypertension, vol. 30, no. 7, pp. 1430–1439, 2012. View at Publisher · View at Google Scholar
  65. F. Sari, E. Eray, and R. Sari, “The effect of quinapril treatment on insulin resistance, leptin and high sensitive C-reactive protein in hypertensive patients,” Clinical Experimental Hypertension, vol. 33, no. 8, pp. 548–551, 2011. View at Publisher · View at Google Scholar
  66. T. Sugiura, Y. Dohi, S. Yamashita et al., “Impact of lipid profile and high blood pressure onendothelial damage,” Journal of Clinical Lipidology, vol. 5, no. 6, pp. 460–466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. M. K. Piya, P. G. McTeman, and S. Kumar, “Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin,” Journal of Endocrinology. In press.
  68. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. D. I. Simon, “Inflammation and vascular injury,” Circulation Journal, vol. 76, no. 8, pp. 1811–1818, 2012. View at Publisher · View at Google Scholar
  70. A. P. Kalogeropoulos, V. V. Georgiopoulou, and J. Butler, “From risk factors to structural heart disease: the role of inflammation,” Heart Fail Clinics, vol. 8, no. 1, pp. 113–123, 2012. View at Publisher · View at Google Scholar
  71. E. Vizzardi, I. Bonadei, B. Piovanelli et al., “Helicobacter pylori and ischemic heart disease,” Panminerva Medica, vol. 53, no. 3, pp. 193–202, 2011.
  72. H. T. Kang, J. K. Kim, J. Y. Shim, H. R. Lee, J. A. Linton, and Y. J. Lee, “Low-grade inflammation, metabolic syndrome and the risk of chronic kidney disease: the 2005 Korean national health and nutrition examination survey,” Journal of Korean Medical Science, vol. 27, no. 6, pp. 630–635, 2012. View at Publisher · View at Google Scholar
  73. I. Kocyigit, M. G. Kaya, O. Orscelik et al., “Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients,” American Journal of Nephrology, vol. 36, no. 1, pp. 11–18, 2012. View at Publisher · View at Google Scholar
  74. D. Luis-Rodríguez, A. Martínez-Castelao, J. L. Górriz, F. De-Álvaro, and J. F. Navarro-González, “Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy,” World Journal of Diabetes, vol. 3, no. 1, pp. 7–18, 2012.
  75. J. Tang, H. Yan, and S. Zhuang, “Inflammation and oxidative stress in obesity-related glomerulopathy,” International Journal of Nephrology, vol. 2012, Article ID 608397, 11 pages, 2012. View at Publisher · View at Google Scholar
  76. M. Hulsmans, B. Geeraert, D. De Keyzer et al., “Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome,” PLoS One, vol. 7, no. 1, Article ID e30414, 2012.
  77. M. G. Rico-Rosillo and G. B. Vega-Robledo, “New trends in macrophages, inflammation and adipose tissue,” Revista Médica del Instituto Mexicano del Seguro Social, vol. 50, no. 1, pp. 39–45, 2012.
  78. R. Stienstra, C. Duval, M. Müller, and S. Kersten, “PPARs, obesity, and inflammation,” PPAR Research, Article ID 95974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. N. Tajik, S. A. Keshavarz, F. Masoudkabir et al., “Effect of diet-induced weight loss on inflammatory cytokines in obese women,” Journal of Endocrinological Investigations. In press.
  80. E. Gremese and G. Ferraccioli, “The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk,” Autoimmunity Reviews, vol. 10, no. 10, pp. 582–589, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Prete, V. Racanelli, L. Digiglio, A. Vacca, F. Dammacco, and F. Perosa, “Extra-articular manifestations of rheumatoid arthritis: an update,” Autoimmunology Review, vol. 11, no. 2, pp. 123–131, 2011. View at Publisher · View at Google Scholar
  82. A. Denes, E. Pinteaux, N. J. Rothwell, and S. M. Allan, “Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target,” Cerebrovascular Disease, vol. 32, no. 6, pp. 517–527, 2011. View at Publisher · View at Google Scholar
  83. C. W. Wu, P. Z. Chao, W. R. Hao, T. H. Liou, and H. W. Lin, “Risk of stroke among patients with rhinosinusitis: a population-based study in Taiwan,” American Journal of Rhinological Allergy, vol. 26, no. 4, pp. 278–282, 2012. View at Publisher · View at Google Scholar
  84. A. Powell, A. J. Teichtahl, A. E. Wluka, and F. M. Cicuttini, “Obesity: a preventable risk factor for large joint osteoarthritis which may act through biomechanical factors,” British Journal of Sports Medicine, vol. 39, no. 1, pp. 4–5, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. L. Beck, Foods that Fight Disease. A Nutrition Guide for Staying Healthy for Life, Penguin Canada, Toronto, Canada, 2010.
  86. J. Daniluk, Meals that Heal Inflammation. Embrace Healthy Living and Eliminate Pain, One Meal at a Time, Random House Canada, Toronto, Canada, 2011.
  87. A. W. Weil, Anti Inflammatory Diet and Pyramid, http://www.drweil.com/drw/u/ART02012/anti-inflammatory-diet, 2012.
  88. Meeting the challenge of living well at a glance 2012, Centers for Disease Control and Prevention, http://www.cdc.gov/chronicdisease/resources/publications/AAG/arthritis.htm, 2012.
  89. B. E. Wisse, “The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity,” Journal of the American Society of Nephrology, vol. 15, no. 11, pp. 2792–2800, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. R. Liu, N. Wei, W. Guo et al., “Octreotide alleviates obesity by reducing intestinal glucose absorption and inhibiting low-grade inflammation,” European Journal of Nutrition. In press. View at Publisher · View at Google Scholar
  91. E. Dean, “Physical therapy in the 21st century (Part II): evidence-based practice within the context of evidence-informed practice,” Physiotherapy Theory and Practice, vol. 25, no. 5-6, pp. 354–368, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. W. Frerichs, E. Kaltenbacher, J. P. van de Leur, and E. Dean, “Can physical therapists counsel patients with lifestyle-related health conditions effectively? A systematic review and implications,” Physiotherapy Theory and Practice, vol. 28, no. 8, pp. 571–587, 2012.
  93. World Health Organization, International Classification of Functioning, Disability and Health, http://www.sustainable-design.ie/arch/ICIDH-2PFDec-2000.pdf, 2002.
  94. S. Hasson, “Editorial-special issue ‘physical therapy practice in the 21st century: a new evidence-informed paradigm and implications’,” Physiotherapy Theory and Practice, vol. 25, no. 5-6, pp. 327–462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. E. S. Ford, M. M. Bergmann, J. Kröger, A. Schienkiewitz, C. Weikert, and H. Boeing, “Healthy living is the best revenge: findings from the European prospective investigation into cancer and nutrition-potsdam study,” Archives of Internal Medicine, vol. 169, no. 15, pp. 1355–1362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. P. M. Ridker, “High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease,” Circulation, vol. 103, no. 13, pp. 1813–1818, 2001. View at Scopus
  97. P. M. Ridker, “Clinical application of C-reactive protein for cardiovascular disease detection and prevention,” Circulation, vol. 107, no. 3, pp. 363–369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. P. M. Ridker, M. Cushman, M. J. Stampfer, R. P. Tracy, and C. H. Hennekens, “Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men,” New England Journal of Medicine, vol. 336, no. 14, pp. 973–979, 1997. View at Publisher · View at Google Scholar · View at Scopus
  99. P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Bodner, R. E. Rhodes, W. C. Miller, and E. Dean, “Smoking cessation and counselling: practices of Canadian physical therapists,” American Journal of Preventive Medicine, vol. 43, no. 1, pp. 67–71, 2012. View at Publisher · View at Google Scholar
  101. E. Dean, Z. Li, W. P. Wong, and M. E. Bodner, “Cardiology best practice-effective health education meets biomedical advances: reducing the ultimate knowledge translation gap,” in Novel Strategies in Ischemic Heart Disease, U. Lakshmanadoss, Ed., pp. 301–318, InTech Publishing, Rijeka, Croatia, 2012.
  102. R. K. Martins and D. W. McNeil, “Review of Motivational Interviewing in promoting health behaviors,” Clinical Psychology Review, vol. 29, no. 4, pp. 283–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. “The 5 A's Cycle,” World Health Organization, http://www.who.int/diabetesactiononline/about/WHO%205A%20ppt.pdf, 2004.
  104. T. van Achterberg, G. G. J. Huisman-De Waal, N. A. B. M. Ketelaar, R. A. Oostendorp, J. E. Jacobs, and H. C. H. Wollersheim, “How to promote healthy behaviours in patients? An overview of evidence for behaviour change techniques,” Health Promotion International, vol. 26, no. 2, pp. 148–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. L. M. Christian, R. Glaser, K. Porter, W. B. Malarkey, D. Beversdorf, and J. K. Kiecolt-Glaser, “Poorer self-rated health is associated with elevated inflammatory markers among older adults,” Psychoneuroendocrinology, vol. 36, no. 10, pp. 1495–1504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. A. Barr and P. G. Conaghan, “Osteoarthritis: a holistic approach,” Clinical Medicine, vol. 12, no. 2, pp. 153–155, 2012.